+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radioembolization Therapy Market - Global Forecast 2025-2030- Product Image
Radioembolization Therapy Market - Global Forecast 2025-2030- Product Image
Sale

Radioembolization Therapy Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055349
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The radioembolization therapy market is transforming rapidly, driven by technology improvements, shifting treatment protocols, and evolving global regulations. This research equips senior decision-makers with actionable market intelligence and strategic perspectives for navigating and capitalizing on shifting landscapes in liver cancer therapy.

Market Snapshot: Radioembolization Therapy Market Growth and Outlook

The radioembolization therapy market grew from USD 1.09 billion in 2024 to USD 1.15 billion in 2025 and is projected to expand at a CAGR of 5.90%, reaching USD 1.54 billion by 2030. Expansion is supported by increasing adoption in both primary and metastatic liver cancer indications and continued innovations in catheter design, imaging, and microsphere technology. Regulatory approvals and value-based care initiatives are reshaping adoption globally.

Scope & Segmentation

  • Component Categories: Catheters; Nuclear Medicine Equipment; Radioactive Microspheres; X-Ray Equipment
  • Treatment Categories: Curative; Palliative
  • Tumor Types: Metastatic Liver Cancer; Primary Liver Cancer
  • Application Procedures: Liver Tumor Intervention; Lobar Therapy; Segmental Therapy
  • End-User Settings: Ambulatory Surgical Centers; Cancer Research Institutes; Hospitals
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina; with focus markets including California, Texas, New York, Florida, Illinois, Pennsylvania, and Ohio), Europe, Middle East and Africa (with countries such as United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, and Taiwan)
  • Technology Foundations: Precision catheter and delivery systems; High-resolution cone-beam CT and functional MRI; Advanced microsphere formulation and isotopic purity; Integrated digital imaging solutions
  • Companies Profiled: Cook Medical, Boston Scientific, Bayer AG, Becton Dickinson & Company, Elekta AB, Fortis Healthcare, Hamilton Health Sciences, Mayo Clinic Health System, Merit Medical Systems, Nordion, Northwestern Memorial HealthCare, Radiological Society of North America, Siemens AG, Sirtex Medical, Stryker, Terumo, United HealthCare Services, Medtronic

Key Takeaways for Senior Decision-Makers

  • Precision-guided radioembolization therapies are gaining momentum, shaped by enhanced imaging and delivery technologies, which support tailored treatment planning and safer dosing profiles.
  • Demographic changes, such as an aging population and growing rates of liver cancers, are driving wider indications and more comprehensive multidisciplinary care approaches.
  • The shift toward value-based care, including real-world data collection and reimbursement models tied to clinical outcomes, is supporting sustained therapy adoption and market expansion.
  • Industry partnerships and hybrid supply models are becoming pivotal, as manufacturers, nuclear pharmacies, and healthcare providers streamline workflows and reinforce supply resilience.
  • Regional investment patterns reveal differing adoption speeds: established networks in the Americas enable standardization and broad access, while Asia-Pacific markets prioritize scaling cost-effective innovations for increasing patient volumes.
  • Ambulatory settings and research institutes are emerging as complementary endpoints to hospitals, accelerating research initiatives and facilitating broader therapy access.

Tariff Impact

Recently introduced United States tariff measures in 2025 have challenged radioembolization supply chains, especially for imported catheters and microspheres. As a result, stakeholders are realigning procurement strategies and exploring local manufacturing or alternative sourcing. Organizations are proactively updating supply contracts and building in-region capabilities to improve cost control and reinforce therapeutic access. These adaptations could lead to more sustainable supply structures and regional self-reliance in the long term.

Methodology & Data Sources

This research applies a robust blend of qualitative and quantitative approaches, including interviews with key opinion leaders in interventional radiology and oncology. Findings are validated through thorough review of clinical trial data, regulatory filings, and patent records. Data triangulation and peer-review processes ensure accuracy and relevance to market stakeholders.

Why This Report Matters

  • Enables informed decision-making by revealing actionable insights on technology development, regulatory shifts, and regional growth trends in the radioembolization therapy market.
  • Supports supply chain strategy and resilience by highlighting the impact of geopolitical factors, tariff structures, and emerging local production ecosystems.
  • Strengthens competitive positioning by profiling leading innovators and strategic collaborations that drive value creation in evolving care and supply models.

Conclusion

This report delivers deep, actionable analysis of the radioembolization therapy market’s evolving landscape. It equips executive leaders with the intelligence needed to guide strategic investments, optimize operations, and proactively manage risk.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing use of radioembolization combined with checkpoint inhibitors in liver cancer management
5.2. Expansion of indications for metastatic colorectal and neuroendocrine tumor radioembolization therapies
5.3. Integration of advanced imaging and dosimetry software enhances personalized treatment planning
5.4. Adoption of holmium-166 microspheres broadens radioembolization options for tumor targeting
5.5. Regulatory approval of radioembolization devices in Asia Pacific drives emerging market penetration
5.6. Strategic alliances between interventional radiology and oncology firms accelerate microsphere innovation
5.7. Outpatient radioembolization protocols reduce hospital stays and drive procedural cost efficiencies
5.8. AI-driven predictive modeling improves patient selection and outcome forecasting in radioembolization therapy
5.9. Advances in glass microsphere manufacturing enhance specific activity and dose delivery precision
5.10. Increasing focus on real-world evidence generation to demonstrate long-term safety and efficacy profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Radioembolization Therapy Market, by Component
8.1. Introduction
8.2. Catheters
8.3. Nuclear Medicine Equipment
8.4. Radioactive Microspheres
8.5. X-Ray Equipment
9. Radioembolization Therapy Market, by Treatment Category
9.1. Introduction
9.2. Curative
9.3. Palliative
10. Radioembolization Therapy Market, by Tumor Type
10.1. Introduction
10.2. Metastatic Liver Cancer
10.3. Primary Liver Cancer
11. Radioembolization Therapy Market, by Application Procedure
11.1. Introduction
11.2. Liver Tumour
11.3. Lobar Therapy
11.4. Segmental Therapy
12. Radioembolization Therapy Market, by End-User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Cancer Research Institutes
12.4. Hospitals
13. Americas Radioembolization Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Radioembolization Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Radioembolization Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Cook Medical Inc.
16.3.2. Boston Scientific Corporation
16.3.3. Bayer AG
16.3.4. Becton Dickinson & Company
16.3.5. Elekta AB
16.3.6. Fortis Healthcare Limited
16.3.7. Hamilton Health Sciences
16.3.8. Mayo Clinic Health System
16.3.9. Merit Medical Systems, Inc.
16.3.10. Nordion Inc.
16.3.11. Northwestern Memorial HealthCare.
16.3.12. Radiological Society of North America, Inc.
16.3.13. Siemens AG
16.3.14. Sirtex Medical Pty Ltd
16.3.15. Stryker Corporation
16.3.16. Terumo Corporation
16.3.17. United HealthCare Services, Inc
16.3.18. Medtronic plc
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. RADIOEMBOLIZATION THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RADIOEMBOLIZATION THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RADIOEMBOLIZATION THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RADIOEMBOLIZATION THERAPY MARKET: RESEARCHAI
FIGURE 26. RADIOEMBOLIZATION THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 27. RADIOEMBOLIZATION THERAPY MARKET: RESEARCHCONTACTS
FIGURE 28. RADIOEMBOLIZATION THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RADIOEMBOLIZATION THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY CATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY NUCLEAR MEDICINE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY NUCLEAR MEDICINE EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY RADIOACTIVE MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY RADIOACTIVE MICROSPHERES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY X-RAY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY X-RAY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY CURATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY CURATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY PALLIATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY PALLIATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY METASTATIC LIVER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY METASTATIC LIVER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY PRIMARY LIVER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY PRIMARY LIVER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY LIVER TUMOUR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY LIVER TUMOUR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY LOBAR THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY LOBAR THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY SEGMENTAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY SEGMENTAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 71. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 72. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 73. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 74. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 75. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 76. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 77. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 78. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 79. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 80. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 81. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 82. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 83. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 84. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 85. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 86. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 87. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 88. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 89. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 90. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 133. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 134. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 135. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 136. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 137. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 138. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 139. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 140. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 141. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 142. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 143. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 144. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 145. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 146. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 147. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 148. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 149. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 150. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 151. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 152. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 163. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 164. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 165. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 166. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 167. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 168. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 169. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 170. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 171. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 172. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 173. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 174. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 175. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 176. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 177. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 178. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 179. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 180. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 181. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 182. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 213. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 214. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 215. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 216. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 217. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 218. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 219. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 220. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 221. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 222. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 233. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 234. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 235. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 236. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 237. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 238. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 239. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 240. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 241. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 242. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 243. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 244. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 245. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 246. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 247. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 248. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 249. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 250. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 251. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 252. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 273. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 274. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 275. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 276. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 277. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 278. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 279. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 280. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 281. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 282. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 283. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 284. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 285. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 286. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 287. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 288. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 289. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 290. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 291. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 292. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 303. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 304. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 305. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 306. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 307. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 308. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 309. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 310. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 311. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 312. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 313. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 314. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 315. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 316. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 317. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2024 (USD MILLION)
TABLE 318. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2025-2030 (USD MILLION)
TABLE 319. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2024 (USD MILLION)
TABLE 320. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2025-2030 (USD MILLION)
TABLE 321. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Radioembolization Therapy Market report include:
  • Cook Medical Inc.
  • Boston Scientific Corporation
  • Bayer AG
  • Becton Dickinson & Company
  • Elekta AB
  • Fortis Healthcare Limited
  • Hamilton Health Sciences
  • Mayo Clinic Health System
  • Merit Medical Systems, Inc.
  • Nordion Inc.
  • Northwestern Memorial HealthCare.
  • Radiological Society of North America, Inc.
  • Siemens AG
  • Sirtex Medical Pty Ltd
  • Stryker Corporation
  • Terumo Corporation
  • United HealthCare Services, Inc
  • Medtronic plc

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.15 billion
Forecasted Market Value ( USD ) by 2030 $ 1.54 billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Applications (Liver Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Applications (Liver Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 210 Pages
  • Global
From
Carcinoid Tumor Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034) - Product Image

Carcinoid Tumor Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Wilms Tumor Market - Product Image

Wilms Tumor Market

  • Report
  • 250 Pages
  • Global
From
Desmoid Tumors - Global Strategic Business Report - Product Image

Desmoid Tumors - Global Strategic Business Report

  • Report
  • 286 Pages
  • Global
From
Tumor Microenvironment Global Market Report 2025 - Product Image

Tumor Microenvironment Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.